Retour
Fourchette du Jour
46,75 €
48,67 €
Fourchette 52 Semaines
13,22 €
94,90 €
Volume
767 602
Moyenne 50J / 200J
71,72 €
/
40,61 €
Clôture Précédente
49,06 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -19,2 | 0,3 |
| P/B | 1,8 | 2,9 |
| ROE % | -11,9 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
116,71 €
+148.1%
Low: 90,00 €
High: 145,00 €
BPA Prévisionnel
-1,72 €
CA Est.
7,1 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,60 €
1,60 € – 1,60 €
|
850 M | 2 |
| FY2029 |
-0,31 €
-0,31 € – -0,31 €
|
630 M | 4 |
| FY2028 |
-1,91 €
-4,04 € – 1,24 €
|
210 M | 6 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -225,81M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-11,86%
ROIC-14,16%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio24,81
Interest Coverage0,00
Valorisation
P/E Ratio
-19,18
P/B Ratio1,79
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -141,20M |
| ROE | -11,86% | ROA | -8,91% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -225,81M |
| ROIC | -14,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,81 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -19,18 | P/B Ratio | 1,79 |
| P/S Ratio | N/A | PEG Ratio | -11,37 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,71B | Enterprise Value | 1,91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -141,20M | -122,53M | -89,62M | -51,32M | -40,01M |
| EPS (Diluted) | -2,40 | -2,34 | -2,43 | -1,44 | -1,20 |
| Gross Profit | -3,90M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -287,57M | -158,23M | -102,78M | -52,56M | -37,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,58B | 903,33M | 482,02M | 97,85M | 111,16M |
| Total Liabilities | 67,54M | 38,49M | 29,05M | 212,99M | 175,89M |
| Shareholders' Equity | 1,52B | 864,84M | 452,97M | -115,14M | -64,74M |
| Total Debt | 6,49M | 3,86M | 5,45M | 260 000,0 | 621 000,0 |
| Cash & Equivalents | 799,62M | 169,51M | 129,79M | 26,09M | 105,31M |
| Current Assets | 1,57B | 891,21M | 473,61M | 93,09M | 109,25M |
| Current Liabilities | 63,29M | 36,02M | 24,74M | 13,01M | 8,66M |